Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Dyskeratosis congenita is a premature aging syndrome characterized by muco-cutaneous features and a range of other abnormalities, including early greying, dental loss, osteoporosis, and malignancy. Dyskeratosis congenita cells age prematurely and have very short telomeres. Patients have mutations in genes that encode components of the telomerase complex (dyskerin, TERC, TERT, and NOP10), important in the maintenance of telomeres. Many dyskeratosis congenita patients remain uncharacterized. Here, we describe the analysis of two other proteins, NHP2 and GAR1, that together with dyskerin and NOP10 are key components of telomerase and small nucleolar ribonucleoprotein (snoRNP) complexes. We have identified previously uncharacterized NHP2 mutations that can cause autosomal recessive dyskeratosis congenita but have not found any GAR1 mutations. Patients with NHP2 mutations, in common with patients bearing dyskerin and NOP10 mutations had short telomeres and low TERC levels. SiRNA-mediated knockdown of NHP2 in human cells led to low TERC levels, but this reduction was not observed after GAR1 knockdown. These findings suggest that, in human cells, GAR1 has a different impact on the accumulation of TERC compared with dyskerin, NOP10, and NHP2. Most of the mutations so far identified in patients with classical dyskeratosis congenita impact either directly or indirectly on the stability of RNAs. In keeping with this effect, patients with dyskerin, NOP10, and now NHP2 mutations have all been shown to have low levels of telomerase RNA in their peripheral blood, providing direct evidence of their role in telomere maintenance in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Eight mutant genes have been identified in dyskeratosis congenita9,38,39,60–64, and all of them encode telomerase or telomere protein components (summarized in Table 1).”
From The telomere syndromes (2012) · cites this paper as [60]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Autosomal dominant forms are caused by mutations in TERT, TERC or the telomere binding protein TRF1-interacting nuclear factor 2 (156-159).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [158]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357
A telomerase component is defective in the human disease dyskeratosis congenita
Mitchell, J. R., Wood, E., & Collins, K. (1999) · Nature · doi:10.1038/990141 · Cited by 1,168 · cited 3×
“Dyskeratosis congenita patients have very short telomeres (10, 15), and some have been shown to have reduced levels of TERC (the RNA component of telomerase) (16, 17).”
BackgroundHeiss, N. S., Knight, S. W., Vulliamy, T. J., Klauck, S. M., Wiemann, S., Mason, P. J., Poustka, A., & Dokal, I. (1998) · Nature Genetics · doi:10.1038/ng0598-32 · Cited by 976 · cited 1×
“The gene mutated in the X-linked form, DKC1, encodes a highly conserved nucleolar protein, called dyskerin (3), that plays an essential role in ribosome biogenesis and pre-mRNA splicing (4), converting specific uridine residues to pseudouridine during the maturation of ribosomal and spliceosomal RNAs (4, 5).”
BackgroundSelf-citationThe RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P. J., & Dokal, I. (2001) · Nature · doi:10.1038/35096585 · Cited by 960 · cited 1×
“The most compelling evidence supporting this view is that autosomal dominant dyskeratosis congenita can result from TERC mutations (18), which cause a reduction in telomerase activity and give rise to disease via haploinsufficiency (19–21).”
BackgroundSelf-citationAdult-onset pulmonary fibrosis caused by mutations in telomerase
Tsakiri, K. D., Cronkhite, J. T., Kuan, P. J., Xing, C., Raghu, G., Weissler, J. C., Rosenblatt, R. L., Shay, J. W., & Garcia, C. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701009104 · Cited by 894
Mutations in TERT, the Gene for Telomerase Reverse Transcriptase, in Aplastic Anemia
Yamaguchi, H., Calado, R. T., Ly, H., Kajigaya, S., Baerlocher, G. M., Chanock, S. J., Lansdorp, P. M., & Young, N. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042980 · Cited by 723 · cited 4×
“The remaining three sequence changes are private mutations that disrupt the NHP2 protein; they were not seen in a screen of 282 control samples of mixed ethnic origin (25), or in an additional 98 healthy individuals of Turkish origin that we have investigated.”
BackgroundInfluentialFunction and synthesis of small nucleolar RNAs
Tollervey, D., & Kiss, T. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80005-1 · Cited by 467 · cited 11×
“Cells were transfected with two predesigned siRNAs to NHP2 or GAR1 (Ambion) at 50 nM, a predesigned negative control siRNA (Ambion) at 30 nM and a mock.”
BackgroundInfluentialArmanios, M., Chen, J.-L., Chang, Y.-P. C., Brodsky, R. A., Hawkins, A., Griffin, C. A., Eshleman, J. R., Cohen, A. R., Chakravarti, A., Hamosh, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508124102 · Cited by 452 · cited 2×
“Heterozygous mutations in the reverse transcriptase component of telomerase (TERT) are associated with a more variable phenotype (23–25, 27, 28), but have also been shown to cause a disease that resembles dyskeratosis congenita (22).”
BackgroundDyskeratosis Congenita and Cancer in Mice Deficient in Ribosomal RNA Modification
Ruggero, D., Grisendi, S., Piazza, F., Rego, E., Mari, F., Rao, P. H., Cordon-Cardo, C., & Pandolfi, P. P. (2003) · Science · doi:10.1126/science.1079447 · Cited by 435 · cited 1×
“Defective pseudouridylation activity has been observed in mice with reduced Dkc1 expression (8) and mouse embryonic stem cells with Dkc1 missense mutations (9), but to date there is no evidence of a similar effect in cells from dyskeratosis congenita patients (10, 11).”
BackgroundSavage, S. A., Giri, N., Baerlocher, G. M., Orr, N., Lansdorp, P. M., & Alter, B. P. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.10.004 · Cited by 414 · cited 2×
“Recently described mutations in the shelterin component TIN2 seem to represent a different mechanism, whereby de novo heterozygous mutations can cause severe disease in the first generation (26).”
BackgroundVulliamy, T. J., Marrone, A., Knight, S. W., Walne, A., Mason, P. J., & Dokal, I. (2006) · Blood · doi:10.1182/blood-2005-07-2622 · Cited by 345
Self-citationWalne, A. J., Vulliamy, T., Marrone, A., Beswick, R., Kirwan, M., Masunari, Y., Al-Qurashi, F.-H., Aljurf, M., & Dokal, I. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm111 · Cited by 316 · cited 6×
“Dyskeratosis congenita patients have very short telomeres (10, 15), and some have been shown to have reduced levels of TERC (the RNA component of telomerase) (16, 17).”
BackgroundInfluentialSelf-citationThe many facets of H/ACA ribonucleoproteins
Meier, U. T. (2005) · Chromosoma · doi:10.1007/s00412-005-0333-9 · Cited by 266
Nhp2p and Nop10p are essential for the function of H/ACA snoRNPs
Henras, A., Henry, Y., Bousquet-Antonelli, C., Noaillac-Depeyre, J., Gélugne, J.-P., & Caizergues-Ferrer, M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.23.7078 · Cited by 236
Vulliamy, T. J., Knight, S. W., Mason, P. J., & Dokal, I. (2001) · Blood Cells, Molecules, and Diseases · doi:10.1006/bcmd.2001.0389 · Cited by 227 · cited 1×
“Dyskeratosis congenita patients have very short telomeres (10, 15), and some have been shown to have reduced levels of TERC (the RNA component of telomerase) (16, 17).”
BackgroundSelf-citationPogačić, V., Dragon, F., & Filipowicz, W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.9028-9040.2000 · Cited by 224 · cited 1×
“Dyskerin, GAR1, NHP2, and NOP10 also form part of the telomerase RNP complex (7, 10, 12) [supporting information (SI) Fig.”
BackgroundCrystal structure of an H/ACA box ribonucleoprotein particle
Li, L., & Ye, K. (2006) · Nature · doi:10.1038/nature05151 · Cited by 222 · cited 3×
“However, an extended search for mutations in the non-RNA binding component, GAR1 (31, 32), has failed to reveal any amino acid substitution in this protein in dyskeratosis congenita patients.”
BackgroundVulliamy, T. J., Walne, A., Baskaradas, A., Mason, P. J., Marrone, A., & Dokal, I. (2005) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2004.12.008 · Cited by 211 · cited 1×
“In other families, heterozygous TERT missense mutations do not clearly segregate with the disease (24), but may be acting as risk factors for aplastic anemia (25).”
BackgroundSelf-citationTelomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita
Wong, J. M. Y., & Collins, K. (2006) · Genes & Development · doi:10.1101/gad.1476206 · Cited by 202 · cited 1×
“Defective pseudouridylation activity has been observed in mice with reduced Dkc1 expression (8) and mouse embryonic stem cells with Dkc1 missense mutations (9), but to date there is no evidence of a similar effect in cells from dyskeratosis congenita patients (10, 11).”
BackgroundArchitecture and assembly of mammalian H/ACA small nucleolar and telomerase ribonucleoproteins
Wang, C., & Meier, U. T. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600181 · Cited by 199 · cited 4×
“Similarly, the stepwise assembly of mammalian H/ACA ribonucleoparticles requires the core proteins dyskerin, NOP10, and NHP2 to be recruited to the site of transcription where they directly associate with the nascent H/ACA snoRNA, whereas GAR1 associates separately at a later stage by replacing the protein NAF1 from t…”
BackgroundInfluentialMochizuki, Y., He, J., Kulkarni, S., Bessler, M., & Mason, P. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402560101 · Cited by 189 · cited 1×
“Defective pseudouridylation activity has been observed in mice with reduced Dkc1 expression (8) and mouse embryonic stem cells with Dkc1 missense mutations (9), but to date there is no evidence of a similar effect in cells from dyskeratosis congenita patients (10, 11).”
BackgroundStepwise RNP assembly at the site of H/ACA RNA transcription in human cells
Darzacq, X., Kittur, N., Roy, S., Shav-Tal, Y., Singer, R. H., & Meier, U. T. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200601105 · Cited by 189
Distinct Biogenesis Pathways for Human Telomerase RNA and H/ACA Small Nucleolar RNAs
Fu, D., & Collins, K. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00196-5 · Cited by 184
Rashid, R., Liang, B., Baker, D. L., Youssef, O. A., He, Y., Phipps, K. R., Terns, R. M., Terns, M. P., & Li, H. (2006) · Molecular Cell · doi:10.1016/j.molcel.2005.11.017 · Cited by 181 · cited 2×
“However, an extended search for mutations in the non-RNA binding component, GAR1 (31, 32), has failed to reveal any amino acid substitution in this protein in dyskeratosis congenita patients.”
BackgroundMarrone, A., Walne, A., Tamary, H., Masunari, Y., Kirwan, M., Beswick, R., Vulliamy, T., & Dokal, I. (2007) · Blood · doi:10.1182/blood-2006-12-062851 · Cited by 178 · cited 1×
“More recently, homozygous mutations in TERT have been shown to cause the more severe form of dyskeratosis congenita (29, 30), and one family has been described in which the autosomal recessive inheritance of a missense mutation in NOP10 gives rise to a classical dyskeratosis congenita phenotype (17).”
BackgroundSelf-citationDragon, F., Pogačić, V., & Filipowicz, W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.3037-3048.2000 · Cited by 166 · cited 1×
“This function is performed in concert with three other proteins (NOP10, NHP2, and GAR1), as well as an H/ACA small nucleolar (sno) RNA molecule that acts as a guide for this RNP complex (6, 7).”
BackgroundTelomerase RNA structure and function: implications for dyskeratosis congenita
Chen, J.-L., & Greider, C. W. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.02.003 · Cited by 161 · cited 1×
“S1] responsible for maintaining the protective repeat sequences at the ends of each chromosome (13, 14).”
BackgroundDyskeratosis congenita: The diverse clinical presentation of mutations in the telomerase complex
Vulliamy, T., & Dokal, I. S. (2007) · Biochimie · doi:10.1016/j.biochi.2007.07.017 · Cited by 133 · cited 1×
“S1] responsible for maintaining the protective repeat sequences at the ends of each chromosome (13, 14).”
BackgroundSelf-citationMarrone, A., Stevens, D., Vulliamy, T., Dokal, I., & Mason, P. J. (2004) · Blood · doi:10.1182/blood-2004-05-1829 · Cited by 126
Self-citationMontanaro, L., Brigotti, M., Clohessy, J. G., Barbieri, S., Ceccarelli, C., Santini, D., Taffurelli, M., Calienni, M., Teruya‐Feldstein, J., Treré, D., et al. (2006) · The Journal of Pathology · doi:10.1002/path.2023 · Cited by 123
The Cbf5–Nop10 complex is a molecular bracket that organizes box H/ACA RNPs
Hamma, T., Reichow, S., Varani, G., & Ferré-D’Amaré, A. R. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1036 · Cited by 122 · cited 1×
“Most of the amino acid substitutions that have been identified in dyskerin map to the PUA domain or the N-terminal extension of the protein that seems to wrap around this domain (32, 33).”
BackgroundXin, Z.-T., Beauchamp, A. D., Calado, R. T., Bradford, J. W., Regal, J. A., Shenoy, A., Liang, Y., Lansdorp, P. M., Young, N. S., & Ly, H. (2007) · Blood · doi:10.1182/blood-2006-07-035089 · Cited by 107 · cited 1×
“Heterozygous missense mutations in the reverse transcriptase component of telomerase (TERT) that abolish telomerase activity have been reported in two large pedigrees with dyskeratosis congenita-like features (22, 23).”
BackgroundDez, C. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.3.598 · Cited by 75
Drachtman, R. A., & Alter, B. P. (1995) · Dermatologic Clinics · doi:10.1016/s0733-8635(18)30104-9 · Cited by 73
Henras, A. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.13.2733 · Cited by 66
Telomerase RNA deficiency in peripheral blood mononuclear cells in X-linked dyskeratosis congenita
Wong, J. M. Y., Kyasa, M. J., Hutchins, L. E., & Collins, K. (2004) · Human Genetics · doi:10.1007/s00439-004-1178-7 · Cited by 60 · cited 1×
“Dyskeratosis congenita patients have very short telomeres (10, 15), and some have been shown to have reduced levels of TERC (the RNA component of telomerase) (16, 17).”
BackgroundDu, H.-Y., Pumbo, E., Manley, P., Field, J. J., Bayliss, S. J., Wilson, D. B., Mason, P. J., & Bessler, M. (2008) · Blood · doi:10.1182/blood-2007-10-120907 · Cited by 60 · cited 1×
“More recently, homozygous mutations in TERT have been shown to cause the more severe form of dyskeratosis congenita (29, 30), and one family has been described in which the autosomal recessive inheritance of a missense mutation in NOP10 gives rise to a classical dyskeratosis congenita phenotype (17).”
BackgroundDokal, I. S. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07040-4 · Cited by 51
Self-citationDelineation of complex chromosomal rearrangements: evidence for increased complexity
Astbury, C., Christ, L. A., Aughton, D. J., Cassidy, S. B., Fujimoto, A., Pletcher, B. A., Schafer, I. A., & Schwartz, S. (2004) · Human Genetics · doi:10.1007/s00439-003-1079-1 · Cited by 39
Drachtman, R. A., & Alter, B. P. (1995) · PubMed · Cited by 13
Cited by
Armanios, M., & Blackburn, E. H. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3246 · Cited by 982
Telomeres and telomerase: three decades of progress
Shay, J. W., & Wright, W. E. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0099-1 · Cited by 924
Telomeres and telomerase in cancer
Artandi, S. E., & DePinho, R. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp268 · Cited by 823
Calado, R. T., & Young, N. S. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0903373 · Cited by 754
Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins
Martínez, P., & Blasco, M. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3025 · Cited by 468
Metadata
- Authors
- Vulliamy, T., Beswick, R., Kirwan, M., Marrone, A., Digweed, M., Walne, A., & Dokal, I.
- Affiliations
- Queen Mary University of London (GB)
- Charité – Universitätsmedizin Berlin (DE)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-06-10
- Volume
- 105
- Issue
- 23
- Pages
- 8073-8078
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2430361
- OpenAlex
- W2035467544
- Cited by
- 334
- References
- 41
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 14 · 2023: 13 · 2022: 17 · 2021: 15 · 2020: 21 · 2019: 12 · 2018: 24 · 2017: 18 · 2016: 14 · 2015: 22 · 2014: 17 · 2013: 21 · 2012: 18
- FWCI
- 19.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- dyskeratosis congenita, NHP2, GAR1, telomerase, telomere maintenance, premature aging, autosomal recessive inheritance, small nucleolar ribonucleoproteins, dyskerin, NOP10, RNA stability, siRNA knockdown
- MeSH terms
- Base Sequence, DNA Mutational Analysis, Female, Genes, Recessive, HeLa Cells, Humans, Male, Molecular Sequence Data, Mutation, Nuclear Proteins, Pedigree, Syndrome, RNA-Binding Proteins, Telomere, Ribonucleoproteins, Small Nuclear, Protein Structure, Secondary, Telomerase, Aging, Premature, Dyskeratosis Congenita, Amino Acid Substitution, Ribonucleoproteins, Small Nucleolar, Mutant Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.